US Stock MarketDetailed Quotes

ACAD ACADIA Pharmaceuticals

Watchlist
  • 16.290
  • +0.080+0.49%
Close Nov 27 16:00 ET
  • 16.290
  • 0.0000.00%
Post 20:01 ET
2.71BMarket Cap20.88P/E (TTM)

ACADIA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
18.28%250.4M
46.44%241.96M
73.75%205.83M
40.45%726.44M
69.27%231.04M
61.96%211.7M
22.79%165.24M
2.59%118.46M
6.83%517.24M
4.38%136.49M
Operating revenue
18.28%250.4M
46.44%241.96M
73.75%205.83M
40.45%726.44M
69.27%231.04M
61.96%211.7M
22.79%165.24M
2.59%118.46M
6.83%517.24M
4.38%136.49M
Cost of revenue
28.96%18.86M
144.40%18.23M
1,276.78%22.95M
309.58%41.64M
641.44%17.89M
584.55%14.62M
179.68%7.46M
-43.49%1.67M
-46.89%10.17M
-5.78%2.41M
Gross profit
17.49%231.54M
41.80%223.73M
56.58%182.88M
35.05%684.8M
58.98%213.15M
53.27%197.08M
19.62%157.78M
3.80%116.8M
9.05%507.07M
4.59%134.08M
Operating expense
-21.56%199.9M
24.92%193.3M
-1.59%167.67M
3.77%758.18M
-1.07%178.21M
59.84%254.85M
-6.53%154.74M
-24.46%170.38M
14.99%730.67M
4.22%180.14M
Selling and administrative expenses
36.17%133.29M
21.98%117.06M
6.67%107.99M
10.15%406.56M
6.77%111.47M
25.33%97.89M
6.75%95.97M
4.71%101.24M
-6.80%369.09M
-1.43%104.4M
Research and development costs
-57.57%66.61M
29.71%76.23M
-13.69%59.68M
-2.75%351.62M
-11.88%66.74M
92.98%156.96M
-22.31%58.77M
-46.34%69.14M
51.02%361.58M
13.14%75.74M
Operating profit
154.77%31.64M
902.21%30.44M
128.39%15.21M
67.18%-73.38M
175.86%34.94M
-87.18%-57.78M
109.02%3.04M
52.59%-53.58M
-31.19%-223.6M
-3.15%-46.06M
Net non-operating interest income expense
59.66%6.59M
39.76%6.36M
44.89%5.51M
160.73%17.23M
31.10%4.76M
79.74%4.13M
684.48%4.55M
3,519.05%3.8M
1,018.44%6.61M
2,713.95%3.63M
Non-operating interest income
59.66%6.59M
39.76%6.36M
44.89%5.51M
160.73%17.23M
31.10%4.76M
79.74%4.13M
684.48%4.55M
3,519.05%3.8M
1,018.44%6.61M
2,713.95%3.63M
Other net income (expense)
-61.80%576K
131.03%386K
-94.10%286K
44.24%5.11M
0
-30.06%1.51M
-150.30%-1.24M
1,325.00%4.85M
52.08%3.54M
-4.93%1.54M
Other non- operating income (expenses)
-61.80%576K
131.03%386K
-94.10%286K
44.24%5.11M
--0
-30.06%1.51M
-150.30%-1.24M
1,325.00%4.85M
52.08%3.54M
-4.93%1.54M
Income before tax
174.42%38.81M
486.19%37.18M
146.73%21M
76.09%-51.04M
197.10%39.7M
-97.40%-52.14M
118.90%6.34M
60.08%-44.94M
-27.41%-213.44M
4.70%-40.89M
Income tax
-53.65%6.04M
-27.46%3.79M
331.86%4.45M
304.98%10.25M
-829.82%-6.09M
1,597.01%13.03M
1,080.36%5.23M
-495.46%-1.92M
621.08%2.53M
341.80%835K
Net income
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
-28.66%-215.98M
3.18%-41.73M
Net income continuous Operations
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
-28.66%-215.98M
3.18%-41.73M
Minority interest income
Net income attributable to the parent company
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
-28.66%-215.98M
3.18%-41.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
-28.66%-215.98M
3.18%-41.73M
Basic earnings per share
150.00%0.2
1,900.00%0.2
137.04%0.1
72.39%-0.37
207.69%0.28
-135.29%-0.4
104.76%0.01
61.43%-0.27
-27.62%-1.34
3.70%-0.26
Diluted earnings per share
150.00%0.2
1,900.00%0.2
137.04%0.1
72.39%-0.37
207.69%0.28
-135.29%-0.4
104.76%0.01
61.43%-0.27
-27.62%-1.34
3.70%-0.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 18.28%250.4M46.44%241.96M73.75%205.83M40.45%726.44M69.27%231.04M61.96%211.7M22.79%165.24M2.59%118.46M6.83%517.24M4.38%136.49M
Operating revenue 18.28%250.4M46.44%241.96M73.75%205.83M40.45%726.44M69.27%231.04M61.96%211.7M22.79%165.24M2.59%118.46M6.83%517.24M4.38%136.49M
Cost of revenue 28.96%18.86M144.40%18.23M1,276.78%22.95M309.58%41.64M641.44%17.89M584.55%14.62M179.68%7.46M-43.49%1.67M-46.89%10.17M-5.78%2.41M
Gross profit 17.49%231.54M41.80%223.73M56.58%182.88M35.05%684.8M58.98%213.15M53.27%197.08M19.62%157.78M3.80%116.8M9.05%507.07M4.59%134.08M
Operating expense -21.56%199.9M24.92%193.3M-1.59%167.67M3.77%758.18M-1.07%178.21M59.84%254.85M-6.53%154.74M-24.46%170.38M14.99%730.67M4.22%180.14M
Selling and administrative expenses 36.17%133.29M21.98%117.06M6.67%107.99M10.15%406.56M6.77%111.47M25.33%97.89M6.75%95.97M4.71%101.24M-6.80%369.09M-1.43%104.4M
Research and development costs -57.57%66.61M29.71%76.23M-13.69%59.68M-2.75%351.62M-11.88%66.74M92.98%156.96M-22.31%58.77M-46.34%69.14M51.02%361.58M13.14%75.74M
Operating profit 154.77%31.64M902.21%30.44M128.39%15.21M67.18%-73.38M175.86%34.94M-87.18%-57.78M109.02%3.04M52.59%-53.58M-31.19%-223.6M-3.15%-46.06M
Net non-operating interest income expense 59.66%6.59M39.76%6.36M44.89%5.51M160.73%17.23M31.10%4.76M79.74%4.13M684.48%4.55M3,519.05%3.8M1,018.44%6.61M2,713.95%3.63M
Non-operating interest income 59.66%6.59M39.76%6.36M44.89%5.51M160.73%17.23M31.10%4.76M79.74%4.13M684.48%4.55M3,519.05%3.8M1,018.44%6.61M2,713.95%3.63M
Other net income (expense) -61.80%576K131.03%386K-94.10%286K44.24%5.11M0-30.06%1.51M-150.30%-1.24M1,325.00%4.85M52.08%3.54M-4.93%1.54M
Other non- operating income (expenses) -61.80%576K131.03%386K-94.10%286K44.24%5.11M--0-30.06%1.51M-150.30%-1.24M1,325.00%4.85M52.08%3.54M-4.93%1.54M
Income before tax 174.42%38.81M486.19%37.18M146.73%21M76.09%-51.04M197.10%39.7M-97.40%-52.14M118.90%6.34M60.08%-44.94M-27.41%-213.44M4.70%-40.89M
Income tax -53.65%6.04M-27.46%3.79M331.86%4.45M304.98%10.25M-829.82%-6.09M1,597.01%13.03M1,080.36%5.23M-495.46%-1.92M621.08%2.53M341.80%835K
Net income 150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M-28.66%-215.98M3.18%-41.73M
Net income continuous Operations 150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M-28.66%-215.98M3.18%-41.73M
Minority interest income
Net income attributable to the parent company 150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M-28.66%-215.98M3.18%-41.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M-28.66%-215.98M3.18%-41.73M
Basic earnings per share 150.00%0.21,900.00%0.2137.04%0.172.39%-0.37207.69%0.28-135.29%-0.4104.76%0.0161.43%-0.27-27.62%-1.343.70%-0.26
Diluted earnings per share 150.00%0.21,900.00%0.2137.04%0.172.39%-0.37207.69%0.28-135.29%-0.4104.76%0.0161.43%-0.27-27.62%-1.343.70%-0.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data